We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – Products

Cancer cells.
Product News

Association for Molecular Pathology Publishes Evidence-Based Recommendations for Tumor Mutational Burden Testing

AMP published a set of evidence-based recommendations for the analytical validation and reporting of tumor mutational burden (TMB) testing as a potential predictive biomarker for immune checkpoint inhibitor (ICI) therapies.
Blue "MIMETAS" logo is positioned in the bottom left. Black background with abstract, colorful patterns resembling microscopic cells.
Whitepaper

Transforming Cancer Drug Discovery With Comprehensive Tumor Models

This whitepaper explores groundbreaking organ-on-a-chip technology and 3D tissue modeling that is closing the translational gap in cancer drug discovery.
Cancer cells.
Product News

Estonia Develops Personalized CAR-T Cell Therapy for Blood Cancer Patients

The Tartu University Hospital, North Estonia Medical Centre, and Icosagen have joined forces to develop and introduce an innovative personalized cell therapy (CAR-T cell therapy) for patients in Estonia.
CD2-CD58 Axis: Targets in Immune Synapse, cancer immunotherapy, autoimmune diseases, immune evasion of tumors, antiviral responses, immune rejection
Product
Advertisement

CD2-CD58 Axis: Targets in Immune Synapse

Sino Biological offers a wide range of recombinant CD2 and CD58 proteins and antibodies to support elucidating key interactions and pathways and shedding light on potential therapeutic strategies.
Cancer cells.
Product News

OncoHost To Present Poster Demonstrating PROphet®’s Application in Multiple Cancer Indications at ASCO 2024

Plasma-based proteomic platform predicts clinical benefit from immune-checkpoint inhibitors in NSCLC, melanoma, and HPV-related cancers.
Cancer cells under a microscope, showing abnormal growth and division.
App Note / Case Study

A Rapid and Robust Solution for Cellular Response Characterization

This app note explores the use of an assay to facilitate rapid monitoring of T-cell function and simultaneous assessment of cell phenotype, activation markers, proliferation, viability and cytokine secretion.
A strand of mRNA.
Product News

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) has announced the grand opening of its new cGMP mRNA manufacturing facility.
Cells.
Product News

Thermo Fisher Scientific Introduces Animal Origin-Free Formulation To Support Scaling of Cell Therapy Manufacturing

Breakthrough medium delivers speed and scale to CAR-T cell therapy manufacturers.
Double helix structure of DNA.
Product News

University of Liverpool To Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical

The UK’s Medical Research Council is funding a 10-patient Phase I study to deliver rapid personalised treatment for lung cancer patients.
Antibodies.
Product News

Therapeutic Potential of CD20 X CD3 Bispecific Antibodies

As of March 2024, the FDA has approved three CD20 × CD3 BsAbs: mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma (R/R FL), glofitamab (Columvi) for relapsed or refractory diffuse B cell lymphoma
Advertisement